ALZNVSBTAI• 6 Months (Normalized)
ALZN vs BTAI (Alzamend Neuro Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Mar, 21 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ALZN Performance $1.83
-1.61%
Alzamend Neuro Inc.
Normalized Baseline0.00%
BTAI Performance $0.07
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
-1.61%
BTAI outperforming by 1.61%
ALZNBTAI
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ALZN BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ALZN Price | ALZN Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $1.83 | -1.61% | $- | - | |
| Sep 16, 2026 | $1.83 | -1.61% | $0.07 | -95.45% | +93.84% |
| Sep 15, 2026 | $1.78 | -4.30% | $0.04 | -96.96% | +92.66% |
| Sep 14, 2026 | $1.75 | -5.91% | $0.05 | -96.93% | +91.02% |
| Sep 11, 2026 | $1.72 | -7.53% | $0.05 | -96.53% | +89.00% |
| Sep 10, 2026 | $1.70 | -8.60% | $0.05 | -96.60% | +88.00% |
| Sep 09, 2026 | $1.68 | -9.68% | $0.05 | -96.80% | +87.12% |
| Sep 08, 2026 | $1.68 | -9.68% | $0.04 | -97.07% | +87.39% |
| Sep 04, 2026 | $1.66 | -10.75% | $0.07 | -94.97% | +84.22% |
| Sep 03, 2026 | $1.70 | -8.60% | $0.12 | -91.97% | +83.37% |
| Sep 02, 2026 | $1.70 | -8.60% | $0.11 | -92.72% | +84.12% |
| Sep 01, 2026 | $1.64 | -11.99% | $0.14 | -90.68% | +78.69% |
| Aug 31, 2026 | $1.60 | -13.98% | $0.16 | -88.91% | +74.93% |
| Aug 28, 2026 | $1.66 | -10.75% | $0.18 | -87.69% | +76.94% |
| Aug 27, 2026 | $1.67 | -10.48% | $0.72 | -51.09% | +40.61% |
Page 1 of 9